Esperion Therapeutics (NASDAQ:ESPR) CFO Benjamin Halladay Sells 7,337 Shares
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) CFO Benjamin Halladay sold 7,337 shares of Esperion Therapeutics stock in a transaction dated Wednesday, December 17th. The stock was sold...